Skip to main content
Neuropsychiatric Disease and Treatment logoLink to Neuropsychiatric Disease and Treatment
. 2024 Dec 11;20:2405–2421. doi: 10.2147/NDT.S476484

Perspectives on Enhanced Measurement-Based Care Among Healthcare Providers, Adults, Adolescent Patients with Major Depressive Disorder and Pediatric Family Members: A Multicenter Online Investigation

Haonan Zhang 1,*, Ping Sun 2,*, Xing Wang 1, Xiaorui Yang 3, Yuru He 1, Tao Yang 1, Yousong Su 1, Yi Fu 4, Qingwei Li 4, Jinhua Sun 5, Jing Liu 6, Jill K Murphy 6, Erin E Michalak 6, Raymond W Lam 6, Jun Chen 1,, Yiru Fang 1,7,8,9,
PMCID: PMC11646382  PMID: 39677510

Abstract

Objective

Measurement-based care (MBC) is an emerging, objective, and systematic evidence-based practice for monitoring symptom severity and treatment efficacy to assist clinicians in developing individualized treatment strategies for patients with major depressive disorder (MDD). This study aimed to identify the barriers and facilitators of enhanced MBC (eMBC) in the outpatient setting to clarify the eMBC utilization dilemma.

Methods

Between September 2022 and June 2023, we collected the opinions of healthcare providers, adult and adolescent patients, and family members of adolescent patients via online surveys. Specifically, we surveyed their acceptance and perspectives on MBC and eMBC primarily through custom-designed Likert scales developed for this study.

Results

We received responses from 270 adult patients, 144 adolescent patients, 109 family members, and 355 healthcare providers. The results showed that 85.3% of patients and family members were willing to use the eMBC intervention. However, adolescent patients responded significantly differently from the other two groups, with lower acceptance and confidence. Among healthcare providers, while only 69.9% used MBC in practice, 94% believed standardized scales would be effective in treatment, and 91.8% were willing to try eMBC. Additionally, we received 277 remarks regarding eMBC from patients and families.

Conclusion

In general, both clinicians and patients looked forward to using eMBC and recognized the potential benefits. However, they still had many concerns about privacy, professionalism, and time consumption. Responses from adolescent patients appeared more conservative and lacked confidence in eMBC. Further implementations are required to explore how eMBC can be operationalized in the outpatient setting to help different patients.

Keywords: measurement-based care, enhanced measurement-based care, major depressive disorder, digital health, implementation, treatment

Introduction

Major depressive disorder (MDD) is a chronic and recurrent psychiatric disease that has become a public health challenge worldwide. Non-response to first-line therapy recommended by guidelines referred to treatment-resistant depression(TRD) affects 20–30% of patients.1 A study from 2001 based on the US Health Survey found that 77.7% of patients with depressive disorder alone had received primary care practitioner visits, but only 15.6% had received appropriate medication treatment.2 Statistics from 2012 still reveal that 24% of patients received any treatment, but only 9% received adequate treatment, and 6% achieved remission.3 A recent multi-center national survey in China found that only approximately 7% of patients received adequate and proper treatment.4 Medication and dosage can directly affect the remission of depression. Therefore, finding a suitable and personalized treatment regimen for patients has become one of the key issues in current clinical practice. Admittedly, it must be jointly formulated collaboratively and continuously adjusted by both clinicians and patients based on the patient’s severity, response, and tolerance to medication.5 The Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines emphasize the need to establish a comprehensive management program while introducing measurement-based care (MBC) and electronic mental health.6 Currently, more clinicians have gradually embraced MBC, an evidence-based practice, while current practice still relies on subjective observations and intuition.7

MBC was initially employed in a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study to assess the response and remission rates to citalopram in patients with MDD.8 It requires patients to systematically and regularly use measurement tools, such as validated rating scales, to assess their post-treatment outcomes before each clinic follow-up visit.8,9 The results of each MBC could serve as an adjunct tool to help clinical decision-making. Due to time constraints, simple and easy-to-use self-rating scales are commonly used for assessment in clinical and research settings.

MBC has been demonstrated to improve outcomes such as symptom remission and adherence,10 shorten the time to remission, track post-treatment outcomes to enable timely adjustments to medication regimens11 and reduce the emergence of TRD.12 Compared to usual standard care, MBC does not increase the number of outpatient visits or have any additional side effects;13 instead, it enhances patient engagement, allowing patients to understand symptom-driven functional improvements better and provides a clear picture of changes in quality of life from baseline to the current visit.14 A randomized controlled trial(RCT) comparing MBC with standard care found that patients using MBC experience medication adjustments at twice the frequency of those receiving standard care. Due to more appropriate medication plans, the former group shows a significantly reduced risk of relapse.12 Furthermore, the implementation and effectiveness of MBC were well documented in a qualitative interview, showing early signs of promise at improving outcomes.15 Therefore, authoritative guidelines, including CANMAT and the American Psychiatric Association(APA), explicitly recommend clinicians apply MBC to guide treatment decisions.6,11,16

However, paper-based MBC is quite cumbersome and time-consuming for both the clinician and the patient and even leads to a series of data quality issues, including inconveniences in querying and archiving, transcription errors, and data loss. Meanwhile, progressively improved digital technology is being applied to health management. It is universally recognized that digital interventions demonstrate great potential in improving mental health outcomes in a cost-effective manner.17 For instance, a Primary Care First model through e-health technology was developed to collect patients’ self-reported outcomes.18 Research on this model has confirmed that it can effectively manage MDD and implement mental health navigation and behavioral activation teletherapy in clinics.19 Simultaneously, a person-centered model of MBC carried by internet-connected devices was initiated in Canada.20 Patients were required to use their computer or smartphone to access a specially developed app or mini program for self-reported assessment before each appointment.21 Unlike traditional MBC, which are limited to non-portable data input, this enhanced MBC (eMBC) allows for a wider variety of data types from patients in their everyday environments. It’s one of eMBC’s quite remarkable advantages and progress. For instance, eMBC delivered via mobile phones may also be used to gather data on patients’ movement, sleep performance, heart rate, etc, with the help of wristbands that have been developed and are on the market. This means that digital technology enables the regular collection of multidimensional data from patients and can even be supplemented with information from family members or specific caregivers.

MBC has been implemented in RCTs to assess its effectiveness in treating MDD for a while. However, intervention methods based on eMBC are still in program design or initial application stages. Mature software capable of undergoing large-scale, rigorous RCTs to validate its effectiveness and feasibility is not yet available. Therefore, Canadian partners and our team conducted a situational analysis in China to identify the drivers and barriers to eMBC implementation.22 It summarizes the facilitating and hindering factors identified at the organizational, patient, and healthcare provider levels. Efficiency and convenience, age, rural settings, cost, and digital literacy may influence whether patients can benefit from eMBC. However, our previous study only focused on stable patients with MDD and did not assess particular age groups, such as young students. Family members who provide daily care for the patient and are closely engaged in the treatment process were also not considered. Furthermore, Email was the only way to recruit volunteers in the previous survey conducted in Canada.23 This likely excluded participants unfamiliar with the Internet in the sampling session. Consequently, there is a pressing demand to expand the diversity of the survey population. Notably, in recent years, MDD has become “younger”. About 40% of patients experience their first onset before age 20, mostly in adolescence,1 a period of rapid social, emotional, and cognitive development and critical life transitions.24 Gaining insight into the acceptance and opinions of adolescent patients regarding eMBC will, therefore, be beneficial for the subsequent program development.

This study aimed to 1) identify facilitators or barriers to implementing eMBC among healthcare providers, adult and adolescent patients with MDD, and pediatric family members; 2) understand clinicians’ knowledge of current MBC, the use of standardized outcome measures (SOM), and the acceptability of eMBC; 3) prepare for developing a novel whole-course management model for MDD treatment applicable to municipal medical institutions in Shanghai.

Method

Participants and Procedure

We conducted a cross-sectional survey involving patients and family members recruited from three hospitals: Shanghai Mental Health Center(SMHC), Children’s Hospital of Fudan University(CHFU), and Shanghai Tongji Hospital(STH). Enrolled participants visited the psychiatric outpatient department from September 2022 to June 2023. Eligible patients were required to be: 1) aged 12–65 years, with the proportion of adolescents aged 12–18 years being at least one-third of the total sample of patients; 2) diagnosed with MDD, as reported in their medical records; 3) middle school educated or higher, with sufficient audiovisual skills to have a good understanding of the research. After successfully enrolling adolescent patients, we would invite the accompanying family members to participate in our study. Before they completed the survey, our research psychiatrists would briefly introduce the concept of MBC and eMBC in clinical practice. Next, they would complete the online study by scanning a QR code in a quiet environment under trained researchers’ guidance.

Another group was focused on in-service healthcare providers, including psychiatrists, nurses, and caretakers. We posted recruitment questionnaires online all over the country. There are no requirements for age, years of experience, or professional title; they only need to be routinely involved in diagnosing and treating MDD.

Our study was approved by the Ethics Committee of Shanghai Mental Health Center, Children’s Hospital Fudan University, and Shanghai Tongji Hospital. All participants were volunteers who signed the informed consent form. For participants under 18, informed consent forms were signed by both them and their legal guardians, such as their parents. Meanwhile, this study complies with the relevant provisions of the Declaration of Helsinki.

Measures

The survey for patients and family members aimed to collect demographic information, familiarity with the Internet, methods of accessing health information online, trust levels, and acceptance of MBC and eMBC. At the end of the survey, each participant was invited to share their viewpoints on eMBC on a voluntary basis. Similarly, the healthcare provider survey focused on demographics, work context, knowledge and confidence in MBC, its application in diagnostics, integration into clinical workflows, and willingness to collaborate with patients on MBC and eMBC.

We provided each group of participants with different scenarios about the clinical application of (e)MBC to help them better understand. Supplement 1 provides detailed descriptions of each scenario. The acceptance survey was presented on a 6-point Likert scale. “Strongly disagree”, “Disagree”, “Slightly disagree”, “Slightly agree”, “Agree”, and “Strongly Agree” were assigned scores of 1, 2, 3, 4, 5, and 6, respectively. A score above 3 indicates agreement with the statement, with higher scores reflecting stronger levels of agreement. Participants were required to express their explicitly favorable or unfavorable opinions for each statement to provide quantitative data on their attitudes and confidence.

Statistical Analysis

All statistical analyses were performed using SPSS 24.0 and R software, version 4.2.3. For data from patients and family groups, we first summarized the frequency distributions or mean ± standard deviation of demographic information and Internet usage. In the analysis of the acceptance survey, the mean and standard deviation for each question were calculated. Because the data for the three groups showed a non-normal distribution, a non-parametric analysis method—the Kruskal—Wallis H-test(K-W)—was employed, followed by Bonferroni correction, to detect differences in perspectives among the three groups. Secondly, we calculated the mean of the total scores for each participant’s responses to quantify the overall acceptance of (e)MBC. Through this process, we obtained the total score for each participant’s acceptance and calculated the mean and standard deviation. To study the independent effects of demographic information, Internet usage, and other variables on the acceptance of (e)MBC among different groups of participants, we first constructed multiple linear regression equations for each group separately. Finally, we created an interaction term between age and group and integrated these data from three groups into a unified multiple-stepwise regression model. The results highlighted significant predictor variables and their respective regression coefficients.

For survey data from healthcare Providers, we simply counted the frequency distribution or mean ± standard deviation of demographics and work conditions. Similarly, the same Likert scoring system was adopted as above to investigate their knowledge, confidence, and acceptance of MBC. The mean ± standard deviation reflects their attitude towards each issue.

Results

The study enrolled 270 adult patients, 144 adolescent patients, and 109 family members. Demographics and Internet use for the three subgroups are described in Table 1. The average age of adult patients was 36 years, and that of the adolescent group was 14.9 years. Females accounted for a little over 70% of each of the three groups. The proportion of urban residents was 72.6% among adult patients, 39.6% among adolescent patients, and 48.6% among family members. The online survey for healthcare providers received 355 valid surveys from 24 provinces and municipalities nationwide, mainly involving in-service clinicians (Table 2). Among them, 51.5% were female, and the average age was 40.6 years. Psychiatrists accounted for as much as 87.3%. The proportion of those working exclusively in outpatient settings was 22.8%, those working exclusively in inpatient settings was 31.3%, and those working in both settings was 41.7%.

Table 1.

Demographics of the Patients and Family Members

Options Adult Patients Adolescent Patients Family Members
N=270, n(%)/`x±s N=144, n(%)/`x±s N=109, n(%)/`x±s
Age 36.0±13.7 14.90±1.7 43.1±4.9
Gender
 Male 73(27.0) 18(12.5) 25(22.9)
 Female 194(71.9) 114(79.2) 83(76.1)
 Other 3(1.1) 12(8.3) 1(0.9)
Residents in Shanghai
 Yes 205(75.9) 105(72.9) 78(71.6)
 No 65(24.1) 39(27.1) 31(28.4)
Residential area
 Urban 196(72.6) 57(39.6) 53(48.6)
 Suburban 66(24.4) 72(50) 48(44)
 Rural 8(3.0) 15(10.4) 8(7.3)
Education
 Primary School 5(1.9) 3(2.1) 2(1.8)
 Middle School 19(7.0) 77(53.5) 11(10.1)
 High School 42(15.6) 38(26.4) 30(27.5)
 Vocational School 15(5.6) 6(4.2) 5(4.6)
 Bachelor’s degree 131(48.5) 6(4.2) 44(40.4)
 Master’s degree or
 professional degree
47(17.4) 0(0.0) 7(6.4)
 On leave status 0(0.0) 10(6.9) 0(0.0)
 Other 11(4.1) 4(2.8) 10(9.2)
Employment
 Full-time job 143(53.0) 5(3.5) 74(67.9)
 Part-time 3(1.1) 0(0.0) 2(1.8)
 Self-employed 18(6.7) 2(1.4) 17(15.6)
 Homemaker 4(1.5) 0(0.0) 11(10.1)
 Unemployed 18(6.7) 1(0.7) 2(1.8)
 Retired 40(14.8) 1(0.7) 2(1.8)
 Student 41(15.2) 135(93.8) 0(0.0)
 Other 3(1.1) 0(0.0) 1(0.9)

Table 2.

Healthcare Providers’ Demographics, Qualifications, and Workload (n = 355)

Option Response n(%),`x±sd
Age 40.6±9.3
Gender Female 183(51.5)
Male 172(48.5)
Other 0(0.0)
Education Technical school 6(1.7)
Associate degree 33(9.3)
Bachelor’s degree 191(53.8)
Master’s degree 80(22.5)
Doctoral Degree 43(12.1)
Other 2(0.6)
Employment Psychiatrist 310(87.3)
General Practitioner 9(2.5)
Neurologist 8(2.3)
Psychotherapist 7(2)
Social Worker 3(0.8)
Nurses 7(2)
Nurse Assistant 0(0.0)
Other Health Professionals 11(3.1)
Primary work setting Outpatient Department 81(22.8)
Inpatient Department 111(31.3)
Inpatient and Outpatient Departments 148(41.7)
Community Clinics 0(0.0)
Chronic Disease Center (CDC) 2(0.6)
Other 13(3.7)
Years of experience in psychiatric work <1 year 27(7.6)
1–5 years 67(18.9)
6–10 years 59(16.6)
11–15 years 68(19.2)
16–20 years 42(11.8)
>20 years 92(25.9)
Hours spent directly treating patients per week <8 61(17.2)
8–20 81(22.8)
20–30 58(16.3)
30–40 70(19.7)
>40 85(23.9)
Number of patients to treat per week 20–50 hours 180(50.7)
50–80 hours 64(18)
80–110 hours 41(11.5)
110–140 hours 30(8.5)
140–160 hours 14(3.9)
160–200 hours 10(2.8)
>200 hours 16(4.5)
Main specialization/key areas Mood disorders 55(15.5)
Clinical Psychology 37(10.4)
Geriatric Psychiatry 32(9)
Child and Adolescent Psychiatry 44(12.4)
General Adult Psychiatry 182(51.3)
Substance Use Disorders 5(1.4)

Patient and Family Member Group

As seen from Table 3, the percentage of people surfing the Internet daily surpassed 90% in all three subgroups. Familiarity with the mobile apps was, in descending order: adult patients (78.1%), adolescent patients (81.1%), and family members (61.5%). The proportion of adult patients who agreed or strongly agreed that they could find the physical and mental health information they desired via the Internet and to distinguish the quality of that information were both 56.3%, but only 34.8% said they had used online resources to manage their health. This compares with 42.3%, 54.2%, and 27.8% in the adolescent subgroup and 46.8%, 43.1%, and 29.4% in the family subgroup. According to the results of the K-W analysis, they only reported no significant discrepancies in their answers regarding the frequency of Internet use, familiarity with WeChat, Source to health information, and Confidence in making decisions using health information online.

Table 3.

Internet Use in the Patients and Family Members

Options Adult Patients Adolescent Patients Family Members Total Difference Adult vs Adolescent Adult vs Family Members Adolescent vs Family Members
Internet use 0.051
 Multiple times a day 251(93.0) 123(85.4) 99(90.8)
 Once a day 9(3.3) 12(8.3) 3(2.8)
 Every few days 5(1.9) 5(3.5) 3(2.8)
 Once a week 2(0.7) 1(0.7) 0(0.0)
 A few times a month 2(0.7) 0(0.0) 1(0.9)
 Rarely or not at all 1(0.4) 3(2.1) 3(2.8)
Smartphone use 0.003 0.004 1.000 0.021
 I have my smartphone 267(98.9) 135(93.8) 108(99.1)
 I use the same smartphone with family or friends 2(0.7) 2(1.4) 0(0.0)
 I do not use a smartphone 1(0.4) 3(2.1) 0(0.0)
 Other 0(0.0) 4(2.8) 1(0.9)
Time of using smartphones. 0.000 0.000 1.000 0.000
 0 years 1(0.4) 7(4.9) 1(0.9)
 Less than one year 2(0.7) 15(10.4) 0(0.0)
 2–3 years 6(2.2) 46(31.9) 5(4.6)
 3–5 years 13(4.8) 28(19.4) 7(6.4)
 More than five years 248(91.9) 48(33.3) 96(88.1)
Internet access 0.000 0.000 0.209 0.038
 Only smartphone 66(24.4) 60(41.7) 29(26.6)
 Smartphone and computer 199(73.7) 77(53.5) 74(67.9)
 Only computer 3(1.1) 2(1.4) 1(0.9)
 Rarely go online 2(0.7) 5(3.5) 3(2.8)
 Never go online 0(0.0) 0(0.0) 2(1.8)
Mobile app familiarity 0.000 1.000 0.002 0.001
 Very familiar 211(78.1) 117(81.3) 67(61.5)
 A little 55(20.4) 26(18.1) 39(35.8)
 Not at all familiar 2(0.7) 0(0.0) 3(2.8)
 Not applicable 2(0.7) 1(0.7) 0(0.0)
Wechat mini-program familiarity 0.059
 Very familiar 230(85.2) 111(77.1) 85(78)
 Slightly familiar 39(14.4) 27(18.8) 23(21.1)
 Not familiar at all 0(0.0) 1(0.7) 1(0.9)
 Not applicable 1(0.4) 5(3.5) 0(0.0)
WeChat usage interval 0.000 0.000 1.000 0.000
 Never 1(0.4) 6(4.2) 1(0.9)
 Several times a day 261(96.7) 104(72.2) 107(98.2)
 Once a day 3(1.1) 16(11.1) 1(0.9)
 Once every few days 5(1.9) 9(6.3) 0(0.0)
 Once a week 0(0.0) 3(2.1) 0(0.0)
 A few times a month 0(0.0) 1(0.7) 0(0.0)
 Rarely or not at all 0(0.0) 5(3.5) 0(0.0)
Gain general health information online 0.000 0.000 1.000 0.001
 Always 131(48.5) 40(27.8) 49(45)
 Sometimes 123(45.6) 80(55.6) 57(52.3)
 Never 16(5.9) 24(16.7) 3(2.8)
Gain mental health information online 0.001 0.001 1.000 0.014
 Always 106(39.3) 39(27.1) 41(37.6)
 Sometimes 141(52.2) 75(52.1) 61(56)
 Never 23(8.5) 30(20.8) 7(6.4)
Source to health information 0.101
 Never to get information 29(5.4) 22(15.3) 2(1.8)
 Official websites (eg, government, state agencies, research institutions, etc.) 121(22.5) 63(43.8) 60(55)
 Online discussion forums 82(15.3) 41(28.5) 25(22.9)
 Online or mobile apps 136(25.3) 64(44.4) 53(48.6)
 Social media (eg, WeChat forum) 162(30.2) 66(45.8) 46(42.2)
 Other 7(1.3) 3(2.1) 10(9.2)
Type of information 0.000 0.000 1.000 0.007
 Never get information 10(1.5) 21(14.6) 2(1.8)
 Medication information (eg, side effects) 137(21.1) 62(43.1) 57(52.3)
 How to manage symptoms 154(23.7) 54(37.5) 56(51.4)
 Health and mental health problems 211(32.5) 97(67.4) 83(76.1)
 General health and mental health services 134(20.6) 41(28.5) 50(45.9)
 Other 4(0.6) 8(5.6) 8(7.3)
Confidence in accessing (mental) health information online. 0.026 0.071 0.105 1.000
 Strongly disagree 4(1.5) 4(2.8) 3(2.8)
 Disagree 15(5.6) 8(5.6) 5(4.6)
 Uncertain 99(36.7) 71(49.3) 50(45.9)
 Agree 129(47.8) 48(33.3) 51(46.8)
 Strongly agree 23(8.5) 13(9) 0(0.0)
Confidence in discerning the quality of information online. 0.029 1.000 0.104 0.029
 Strongly disagree 7(2.6) 1(0.7) 3(2.8)
 Disagree 12(4.4) 8(5.6) 3(2.8)
 Uncertain 99(36.7) 57(39.6) 56(51.4)
 Agree 136(50.4) 53(36.8) 45(41.3)
 Strongly agree 16(5.9) 25(17.4) 2(1.8)
Confidence in making decisions using health information online. 0.182
 Strongly disagree 14(5.2) 5(3.5) 4(3.7)
 Disagree 27(10.0) 16(11.1) 11(10.1)
 Uncertain 115(42.6) 64(44.4) 61(56)
 Agree 102(37.8) 45(31.3) 32(29.4)
 Strongly Agree 12(4.4) 14(9.7) 1(0.9)
Previously used online resources to help manage health. 0.028 0.029 0.449 1.000
 Yes 94(34.8) 40(27.8) 32(29.4)
 No 149(55.2) 73(50.7) 60(55)
 Uncertain 27(10.0) 31(21.5) 17(15.6)

Notes: The fifth column of the table shows the p-values after the K-W test for the three groups, and the sixth, seventh, and eighth columns show the Bonferroni-corrected p-values after pairwise comparisons.

The average acceptance and confidence in standard MBC ranged from highest to lowest, as follows: the adult patients (5.04), the family members (5.02), and the adolescent patients (4.46), with an overall mean of 4.88. The order in which the average acceptance and confidence in eMBC were ranked from highest to lowest was the adult patients (4.86), the family members (4.74), and the adolescent patients (4.40), with an overall mean of 4.70. (Table 4) It is worth noting that there were statistically significant differences between adult and adolescent patients regarding their acceptance of (e)MBC for each issue in the questionnaire; however, there was no significant difference among family members and adult patients. Supplement 2 summarizes the response proportions for each question in the (e)MBC acceptance survey across the three groups and the proportion of positive attitudes for each question. The results indicate that all acceptance-related questions received over 80% agreement. Among adult patients, all questions had an agreement rate of over 90%, except for “I would be willing to use resources on the Internet, such as those described in the above scenario about eMBC, to help me manage my depression”, which had an agreement rate of 87.04%. In contrast, the adolescent group showed a 79.17% agreement rate for this question.

Table 4.

Patient Acceptability of Standard MBC and eMBC

Options Adult Patients Adolescent Patients Pediatric Family Members ALL Total Difference Adult vs Patients Adult vs Family Members Adolescent vs Family Members
Acceptability of standard MBC
I would like to (have my child) spend 5 minutes completing a questionnaire before each follow-up appointment with my doctor. 5.00±0.93 4.63±1.16 4.93±0.94 4.89±1.01 0.002 0.001 1.000 0.101
I (and my child) want to be more actively involved in my own treatment decisions for my depression. 5.25±0.83 4.52±1.17 5.36±0.71 5.07±0.98 0.000 0.000 1.000 0.000
I believe documenting changes in my (child’s) depressive symptoms with a short questionnaire would help me with my (child’s) depression. 4.94±1.02 4.27±1.27 4.83±1.00 4.73±1.13 0.000 0.000 0.709 0.001
I believe documenting changes in my (child’s) depressive symptoms with a short questionnaire would help me (my child and me) and my doctor discuss my treatment for depression. 5.02±0.95 4.45±1.23 4.97±0.88 4.85±1.05 0.000 0.000 1.000 0.001
I believe that using the questionnaire described in the scenario will help understand my (child’s) depression condition. 5.00±0.93 4.42±1.20 5.03±0.87 4.85±1.03 0.000 0.000 1.000 0.000
Acceptability of eMBC
I would be willing to use resources on the Internet, such as those described in the above scenario, to help manage my (child’s) depression. 4.77±1.07 4.28±1.25 4.81±1.00 4.64±1.13 0.000 0.000 1.000 0.001
I am willing to (have my child) use a phone app to track my symptoms if my doctor recommends it. 4.94±1.02 4.46±1.13 4.73±1.02 4.76±1.07 0.000 0.000 0.147 0.086
I believe my child could use a cell phone app to complete a short depressive symptom questionnaire regularly (eg, every two weeks) 4.87±0.99 4.45±1.15 4.68±0.95 4.71±1.04 0.000 0.000 0.146 0.373

Notes: Columns 2 to 5 of the table are the mean and standard deviation of the Likert scores, column 6 is the p-value of the three groups after the K-W test, and columns 7, 8 and 9 are the Bonferroni-corrected p-values after pairwise comparison.

Regression analysis revealed that the only predictor determining adolescents’ acceptance of both MBC and eMBC was their confidence in accessing (mental) health information online, which could positively affect acceptance. The only shared influencing factor among adults was the frequency of gaining general health information online. The number of sources to health information was the only statistically significant positive predictor of MBC acceptance in the adult group. The detailed impact coefficients and significance levels are presented in Table 5. In the multiple stepwise regression model, MBC and eMBC were separately used as dependent variables to compare the similarities and differences in predictive models significantly affecting each outcome. As shown in Table 6, the final predictors included-“Gaining general health information online”, “Source of health information, Confidence in accessing (mental) health information online”, “Age”, “Time spent using a smartphone, and Previous use of online resources to help manage health”. The first three were common predictors for both outcomes (all p-values < 0.01).

Table 5.

Predictors of Acceptance of MBC (Adult and Adolescent Patient Groups)

Options MBC eMBC
Adults Adolescents Adults Adolescents
(Constant) 5.49** 1.86 5.97** 1.97
Age 0.00 0.08 0.00 0.06
Gender −0.06 −0.26 −0.17 −0.21
Residents in Shanghai −0.02 −0.21 0.16 −0.11
Residential area −0.08 0.01 0.08 −0.08
Education 0.01 −0.07 0.02 0.05
Employment 0.01 0.03 0.03 0.05
Internet use −0.11 0.21 −0.08 0.13
Smartphone use 0.49 0.28 0.13 −0.17
Time of using smartphone. −0.05 0.12 −0.05 −0.07
Internet access 0.07 −0.11 0.04 0.01
Mobile app familiarity −0.03 −0.05 −0.45** −0.04
Wechat mini-program familiarity −0.06 −0.04 0.22 −0.03
WeChat usage interval −0.37* −0.06 −0.23 −0.01
Gain general health information online −0.41** 0.01 −0.55** −0.01
Gain mental health information online 0.14 0.06 −0.02 0.03
Source to health information 0.13** 0.09 0.10 0.04
Type of information 0.01 0.17 0.00 0.19
Confidence in accessing (mental) health information online. 0.02 0.34** 0.09 0.47**
Confidence in discerning the quality of information online. 0.04 0.05 −0.06 −0.09
Confidence in making decisions using health information online. 0.01 −0.13 0.04 0.07
Previously used online resources to help manage health. −0.13 0.09 −0.16 0.00

Notes: In the table, “*” represents the p-value of the coefficient ≤0.05, and “**” represents the p-value of the coefficient≤0.01.

Table 6.

Results of the Multiple Stepwise Regression of (e)MBC Acceptance

Options MBC eMBC
Age 0.008 \
Time of using smartphone. 0.087 \
Gain general health information online −0.251 −0.305
Source to health information 0.118 0.130
Confidence in accessing (mental) health information online. 0.147 0.226
Previously used online resources to help manage health. \ −0.158

Healthcare Provider Group

In Table 7, only the Likert scores for the feasibility survey of MBC did not exceed 4 points, the remaining questions were all four and above. They generally expressed a positive inclination toward descriptive statements highlighting the benefits of MBC, with a mean Likert score of 4.80, and overall confidence in applying MBC to assist clinical diagnosis was 4.35. However, response scores were only 3.72 for “integrating MBC into daily workflows”, while acceptance of “using eMBC in collaboration with patients” was relatively high at 4.66.

Table 7.

Healthcare Providers’ Knowledge, Confidence, and Acceptance of MBC (n = 355)

Options Likert Scores
Knowledge and beliefs of MBC
Standardized questionnaires and scales are valid for assessing the severity of symptoms. 4.82±0.78
MBC can improve patient prognosis. 4.63±0.90
MBC helps make treatment decisions. 4.84±0.78
The use of MBC at each visit helps to monitor treatment effects 4.88±0.78
MBC contributes to the reinforcement of patients’ treatment. 4.79±0.75
Patients find MBC helpful. 4.65±0.85
MBC contributes to educating patients about their mental symptoms and illness. 4.83±0.74
MBC enables patients to have better engagement in medical decision-making. 4.84±0.77
MBC facilitates collaborative treatment with other healthcare professionals for the same patient. 4.89±0.72
Average 4.80±0.65
Clinical Application of MBC
MBC is highly important and valuable in aiding clinical decision-making. 4.78±0.83
I have received training on using MBC and applying its results to guide clinical decision-making. 4.15±1.25
I have enough knowledge to explain the MBC ratings. 4.43±1.05
I use MBC to monitor the patient’s therapeutic progress at each visit. 4.06±1.18
I will discuss the MBC score with the patient. 4.34±1.09
Average 4.35±0.89
Feasibility of using MBC
MBC is easy to integrate into my daily workflow. 3.70±0.67
If my hospital provides training and resources, I will use MBC. 3.92±0.67
I will use the data collected from MBC to evaluate my clinical practice. 3.83±0.68
My patients are willing to complete MBC at each follow-up visit. 3.53±0.77
I will be more likely to use MBC if it’s automated, electronic, and easy to explain. 4.00±0.66
I am too busy to know how to integrate MBC into my current workflow. 3.32±0.88
Average 3.72±0.53
Acceptability of use of eMBC
The mobile app will make MBC easier to use. 4.86±0.82
I would like to use MBC with my patients via a mobile app. 4.76±0.88
My patients would find the above mobile app easy to use. 4.52±0.94
My patients are willing to use the app to track their prognosis. 4.51±0.93
Average 4.66±0.79

94.08% of participants believed standardized surveys and scales are valid for assessing the severity of symptoms. 95% of them acknowledged it’s highly important and valuable in aiding clinical decision-making. However, only 80.85% would discuss MBC scores with patients, 75.21% reported receiving related training, and 69.86% would use MBC to monitor the patient’s therapeutic progress at each visit. Additionally, 46.76% felt too busy to integrate MBC into their current workflow (Supplement 3).

Comments on eMBC

A total of 170 adults, 40 adolescents with depression, and 67 family members completed valid comments. Of these, 213 expressed explicit favorable or supportive attitudes toward implementing eMBC. 43 patients mentioned “convenience”, and “Real-time tracking of conditions” making them the most frequently mentioned advantage. 48 participants expressed clear opposition or negative concerns, such as “unreliable and unsafe”, “prone to make children addicted to the Internet and dependent on mobile phones”, “dislike forms and questionnaires”, and “cannot fully reflect the objective truth”.

In addition, there were many suggestive opinions in the comments. 14 participants emphasized the importance of privacy. 22 participants wished to have an official team to manage, review, or provide professional assistance. Other suggestions for the development and design of eMBC include:

1) Setting up a communication website;

2) Connecting to the official hospital system;

3) Documenting changes during the healing process;

4) Including medical knowledge for learning;

5) Providing font enlargement capabilities for the elderly;

6) Offering a psychological helpline;

7) Designing simple interfaces;

8) Adding reminders for taking medication.

Discussion

To our knowledge, this is the first mixed methods study to investigate the acceptance of standard MBC and eMBC use among adolescent patients and families. We compared attitudes towards eMBC among adult patients, adolescent patients, and pediatric families and also analyzed knowledge, confidence, concerns, and acceptance from healthcare providers. A large sample of 878 participants, aged 12–65 years, was collected in the study. And there is no extreme bias in the distribution of patients and their families regarding residential status (urban and rural), years of education, and employment, making results broadly representative. The included healthcare providers were primarily undergraduate and master’s degree holders. Gender, years of experience in psychiatric work, primary work setting (inpatient or outpatient), and hours spent directly treating patients per week were all approximately evenly distributed. These results enhance our research’s credibility and make the sample more broadly representative.

Many of our findings are similar to those previously surveyed by Canadian partners with our team.22,23 Participants were optimistic about eMBC and expressed a strong willingness to use it. The results revealed that adolescent and adult patients’ rates of mobile phone ownership exceeded 90%. The frequency and time spent accessing the internet and mobile phones were considerable. Such widespread use of smartphones has laid a solid foundation for the future development of eMBC services. The general acceptance of eMBC was high, similar to findings in previous studies on attitudes toward using mobile phones to monitor and manage depression, anxiety, and stress.25 Patients’ and families’ acceptance of eMBC was affected by several factors: Those who gained general health information online more frequently, had more sources of information, were more confident in accessing (mental) health information online, and previously used online resources to help manage health demonstrated higher acceptance. Additionally, the first three factors just mentioned similarly affected MBC’s acceptance.

We added a novel aspect that included observations from adolescent patients and families and found a surprising conclusion. Adolescent patients used their mobile phones significantly less than adults due to school regulations (most Chinese students are banned from carrying digital devices in school), but their familiarity with mobile phones and confidence in accessing high-quality health information on the Internet was no different from those of the other two groups. It’s surprising that adolescent patients were more conservative in smartphone use and using the Internet to manage their health. They also had the least acceptance and confidence in eMBC. According to regression analysis, the only factor influencing adolescents’ acceptance of (e)MBC is confidence in accessing (mental) health information online. Moreover, since they have been exposed to the Internet since childhood, their conservative attitudes are worth further insight through qualitative analysis such as semi-structured interviews. Based on the current evidence, we hypothesize that it may be related to adolescents’ restricted time on their smartphones, lack of sufficient knowledge of the Internet to distinguish between high and low quality, increased concern for privacy and fear of being known by parents or peers, and lack of awareness of the long-term benefits of symptom tracking. It’s encouraging to note that previous studies found that high-intensity digital technology enabled adolescents to be more proactive in their mental health care.26 This indicated that Internet technology applied to clinical practice does not have intractable obstacles to overcome despite the relatively conservative attitudes of adolescent patients we surveyed. And worth pointing out, to date, although versions of the classic scales suitable for assessing depressive symptoms in adolescents have been pioneered,27 adolescents still lack well-grounded measures to gauge disease, symptoms, and functions compared to well-established assessments for adults.28 This could be a key factor hindering adolescent patients’ full benefit from eMBC in the future. For instance, the classic Sheehan Disability Scale (SDS) is widely used to assess functional impairment in adults across work, social, and family domains. However, a scale comparable to the SDS to evaluate adolescents’ academic functioning, social interactions, and family life has not yet been broadly implemented.

Additionally, our study encouraged participants to think creatively about eMBC, which would facilitate the future development of the eMBC program better to address the needs of patients and their families. Patients and their families expected eMBC to be like a reliable “housekeeper”, which could save clinicians’ workload while ensuring effective treatment. We noted that they repeatedly mentioned certain perceptions about the desired functions of eMBC. Privacy protection, records and reminders of medication regimens, professionalism and reliability, and tailored care for particular populations, such as font enlargement for the elderly and preventing smartphone dependence in children, should be prioritized in the subsequent eMBC program development. A qualitative study was conducted to determine the needs of patients and healthcare providers before establishing the Pathway Platform, a digital MBC platform for patients with MDD. Keywords such as simplicity, interaction, health tracker, easy to use, and reliable were frequently mentioned.29 Combined with our results, developing an intervention model for eMBC requires great attention to the system’s user-friendly design, interactivity, and reliability to ensure that it meets the actual expectations of patients. Furthermore, approximately 20–30% of patients have encountered inadequate response or resistance to treatment and then repeatedly adjusted their medication.1,30 This is one of the key challenges in MDD treatment. Patients hoped eMBC could function as a medication reminder, record patient adherence, detect failure to respond to treatment promptly and assist clinicians in changing the treatment program to improve outcomes.31

The healthcare providers surveyed, for the most part, were in favor of having MBC and eMBC as assistants for treatment and were proficient in applying them in practice. However, MBC has not been extensively utilized in treating patients with MDD, although theoretically, grounded evidence has demonstrated the benefits of MBC.9,32–34 Our study supported that less than 50% of them would incorporate it into their practice, while in previous studies, this number was fewer than 20%.35,36 According to our survey results, we assume that this might be associated with the fact that paper-based assessments are not user-friendly and add to the burden of outpatient care because they are more optimistic about using MBC if it is automated and electronic and outcomes are easy to interpret. This is similar to the findings of a previous Canadian study that demonstrated a dramatic increase in adherence when patients had access to an online-based MBC instead of a paper-based MBC for follow-up.37 After all, eMBC has greater flexibility and continuity in data collection to amplify the strengths of traditional assessments.7 However, clinicians were also concerned about time constraints and the issue of confidentiality imposed on them and their patients.38

Consequently, We need to be aware that the key to successful implementation of eMBC interventions is not only to adequately address the burdens and needs of clinicians, patients, and even their families but also to consider the broader healthcare environment. Shanghai was chosen as the setting for recruiting patients primarily because its psychiatric healthcare system is relatively advanced, with ongoing efforts to improve tiered diagnosis and referral systems. Healthcare reforms are moving towards a “patient-friendly” and “patient-centered” model, as demonstrated by initiatives like the establishment of a “Patient Experience Department” to accommodate diverse patient populations. Additionally, the city’s inclusivity and support for digital mental health initiatives are favorable factors promoting the implementation of eMBC.

The primary reason for initially implementing eMBC first in tertiary hospitals is that, in the current healthcare environment, the public clearly tends to rely more on higher-level, advanced tertiary public hospitals.39 We hope to develop an implementation of eMBC to be applicable to the full-course management model for MDD treatment in Shanghai’s municipal healthcare institutions. This would ideally meet the needs of both municipal psychiatric hospitals and tertiary general hospitals’ psychiatry departments, as well as psychology departments in general children’s hospitals, thereby covering a range of MDD patients from children and adolescents to adults.

We note four limitations to this study. First, there may be a sample selection bias. Our patients were all recruited from large tertiary hospitals without primary hospitals and district mental health centers. The results may not be generalizable to patients with mild symptoms or those with financial difficulties who prefer seeking clinic visits locally to minimize travel time and medical expenses. Second, all enrolled subjects were willing to participate in the surveys after their clinician’s recommendation, excluding some patients who were sick of completing the questionnaires. This may lead to the inclusion of fewer patients who are reluctant to use eMBC for follow-up management. Third, although we strongly recommended enrolling adolescent patients and their families together, not all the parents of enrolled adolescents were willing to participate, and therefore, we could not identify a family’s acceptance of eMBC by pairwise matching. Fourth, the Likert scale transforms actual attitudes into discrete categorical variables and may be infused with the researchers’ subjective perceptual bias, which may introduce some loss of information and bias.

Conclusion

Overall, participants had positive attitudes toward the intervention of using eMBC to manage MDD. Among them, adolescent patients were more conservative. The use of eMBC in clinical settings could potentially be significantly enhanced if the concerns of different patients and healthcare providers are addressed and eMBC is seamlessly integrated into the treatment process without additional time costs. In the future, standardized structured interviews and focus group symposia could be implemented to better understand the attitudes, concerns, and design perspectives of different types of patients, families, and healthcare providers and intervene on key factors affecting acceptability.

Funding Statement

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Jun Chen received support for this study from the National Natural Science Foundation of China (81761128032, 81930033, 81771465), the Clinical Research Plan of SHDC (SHDC12020126), Key Area Research and Development Program of Guangdong Province (2018B030334001), Clinical Research Center of Shanghai Mental Health Center Key Project (CRC2021ZD01, CRC2021DX01), Shanghai Key Clinical Specialties Construction Project (Psychiatry and Mental Health), Shanghai Clinical Research Center for Mental Health (19MC1911100).

Data Sharing Statement

All data generated or analyzed during this study are included in this published article.

Disclosure

The authors report no conflicts of interest in this work.

References

  • 1.Malhi GS, Mann JJ. Depression. Lancet. 2018;392(10161):2299–2312. doi: 10.1016/S0140-6736(18)31948-2 [DOI] [PubMed] [Google Scholar]
  • 2.Young AS, Klap R, Sherbourne CD, Wells KB. The quality of care for depressive and anxiety disorders in the United States. Arch Gen Psychiatry. 2001;58(1):55–61. doi: 10.1001/archpsyc.58.1.55 [DOI] [PubMed] [Google Scholar]
  • 3.Pence BW, JK O, Gaynes BN. The depression treatment cascade in primary care: a public health perspective. Curr Psychiatry Rep. 2012;14(4):328–335. doi: 10.1007/s11920-012-0274-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Lu J, Xu X, Huang Y, et al. Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study. Lancet Psychiatry. 2021;8(11):981–990. doi: 10.1016/s2215-0366(21)00251-0 [DOI] [PubMed] [Google Scholar]
  • 5.Rafeyan R, Papakostas GI, Jackson WC, Trivedi MH. Inadequate response to treatment in major depressive disorder: augmentation and adjunctive strategies. J Clin Psychiatry. 2020;81(3). doi: 10.4088/JCP.OT19037BR3 [DOI] [PubMed] [Google Scholar]
  • 6.Lam RW, McIntosh D, Wang J, et al. Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 1. disease burden and principles of care. Can J Psychiatry. 2016;61(9):510–523. doi: 10.1177/0706743716659416 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Hsin H, Fromer M, Peterson B, et al. Transforming psychiatry into data-driven medicine with digital measurement tools. NPJ Digit Med. 2018;1:37. doi: 10.1038/s41746-018-0046-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163(1):28–40. doi: 10.1176/appi.ajp.163.1.28 [DOI] [PubMed] [Google Scholar]
  • 9.Scott K, Lewis CC. Using measurement-based care to enhance any treatment. Cogn Behav Pract. 2015;22(1):49–59. doi: 10.1016/j.cbpra.2014.01.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Yeung AS, Jing Y, Brenneman SK, et al. Clinical outcomes in measurement-based treatment (Comet): a trial of depression monitoring and feedback to primary care physicians. Depress Anxiety. 2012;29(10):865–873. doi: 10.1002/da.21983 [DOI] [PubMed] [Google Scholar]
  • 11.Davidson JR. Major depressive disorder treatment guidelines in America and Europe. J Clin Psychiatry. 2010;71 Suppl E1:e04. doi: 10.4088/JCP.9058se1c.04gry [DOI] [PubMed] [Google Scholar]
  • 12.Guo T, Xiang YT, Xiao L, et al. Measurement-based care versus standard care for major depression: a randomized controlled trial with blind raters. Am J Psychiatry. 2015;172(10):1004–1013. doi: 10.1176/appi.ajp.2015.14050652 [DOI] [PubMed] [Google Scholar]
  • 13.Rush AJ. Isn’t it about time to employ measurement-based care in practice? Am J Psychiatry. 2015;172(10):934–936. doi: 10.1176/appi.ajp.2015.15070928 [DOI] [PubMed] [Google Scholar]
  • 14.Hawley S, Yu J, Bogetic N, et al. Digitization of measurement-based care pathways in mental health through REDCap and electronic health record integration: development and usability study. J Med Internet Res. 2021;23(5):e25656. doi: 10.2196/25656 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Wray LO, Oslin DW, Leong SH, et al. Enhancing implementation of measurement-based mental health care in primary care: a mixed-methods study. Psychiatr Serv. 2023;74(7):746–755. doi: 10.1176/appi.ps.20220140 [DOI] [PubMed] [Google Scholar]
  • 16.Mayes TL, Deane AE, Aramburu H, Yagnik K, Trivedi MH. Improving identification and treatment outcomes of treatment-resistant depression through measurement-based care. Psychiatr Clin North Am. 2023;46(2):227–245. doi: 10.1016/j.psc.2023.02.002 [DOI] [PubMed] [Google Scholar]
  • 17.Buntrock C. Cost-effectiveness of digital interventions for mental health: current evidence, common misconceptions, and future directions. Front Digit Health. 2024;6:1486728. doi: 10.3389/fdgth.2024.1486728 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Trivedi MH, Jha MK, Kahalnik F, et al. VitalSign(6): a primary care first (PCP-First) model for universal screening and measurement-based care for depression. Pharmaceuticals. 2019;12(2). doi: 10.3390/ph12020071 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Trombello JM, South C, Cecil A, et al. Efficacy of a behavioral activation teletherapy intervention to treat depression and anxiety in primary care VitalSign6 program. Prim Care Companion CNS Disord. 2017;19(5). doi: 10.4088/PCC.17m02146 [DOI] [PubMed] [Google Scholar]
  • 20.Uher R. Person-centered measurement-based care for depression. World Psychiatry. 2016;15(3):238–239. doi: 10.1002/wps.20363 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Chiauzzi E, Wicks P. Beyond the therapist’s office: merging measurement-based care and digital medicine in the real world. Digit Biomark. 2021;5(2):176–182. doi: 10.1159/000517748 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Murphy JK, Michalak EE, Liu J, et al. Barriers and facilitators to implementing measurement-based care for depression in Shanghai, China: a situational analysis. BMC Psychiatry. 2021;21(1):430. doi: 10.1186/s12888-021-03442-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Cheung BS, Murphy JK, Michalak EE, et al. Barriers and facilitators to technology-enhanced measurement based care for depression among Canadian clinicians and patients: results of an online survey. J Affect Disord. 2023;320:1–6. doi: 10.1016/j.jad.2022.09.055 [DOI] [PubMed] [Google Scholar]
  • 24.Thapar A, Eyre O, Patel V, Brent D. Depression in young people. Lancet. 2022;400(10352):617–631. doi: 10.1016/s0140-6736(22)01012-1 [DOI] [PubMed] [Google Scholar]
  • 25.Proudfoot J, Parker G, Hadzi Pavlovic D, Manicavasagar V, Adler E, Whitton A. Community attitudes to the appropriation of mobile phones for monitoring and managing depression, anxiety, and stress. J Med Internet Res. 2010;12(5):e64. doi: 10.2196/jmir.1475 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.McKenna S, Piper S, Capon W, et al. The polarization of clinician and service staff perspectives after the use of health information technology in youth mental health services: implementation and evaluation study. JMIR Hum Factors. 2023;10:e42993. doi: 10.2196/42993 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Nandakumar AL, Vande Voort JL, Nakonezny PA, et al. Psychometric properties of the patient health questionnaire-9 modified for major depressive disorder in adolescents. J Child Adolesc Psychopharmacol. 2019;29(1):34–40. doi: 10.1089/cap.2018.0112 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Stoddard JE. The EDI-YC: a new measure of emotion dysregulation in young children. J Am Acad Child Adolesc Psych. 2023. doi: 10.1016/j.jaac.2023.06.017 [DOI] [PubMed] [Google Scholar]
  • 29.McCue M, Khatib R, Kabir C, et al. User-centered design of a digitally enabled care pathway in a large health system: qualitative interview study. JMIR Hum Factors. 2023;10:e42768. doi: 10.2196/42768 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Papakostas GI, Jackson WC, Rafeyan R, Trivedi MH. Overcoming challenges to treat inadequate response in major depressive disorder. J Clin Psychiatry. 2020;81(3). doi: 10.4088/jcp.Ot19037br4 [DOI] [PubMed] [Google Scholar]
  • 31.Trivedi MH, Papakostas GI, Jackson WC, Rafeyan R. Implementing measurement-based care to determine and treat inadequate response. J Clin Psychiatry. 2020;81(3). doi: 10.4088/jcp.Ot19037br1 [DOI] [PubMed] [Google Scholar]
  • 32.Zhu M, Hong RH, Yang T, et al. The efficacy of measurement-based care for depressive disorders: systematic review and meta-analysis of randomized controlled trials. J Clin Psychiatry. 2021;82(5). doi: 10.4088/JCP.21r14034 [DOI] [PubMed] [Google Scholar]
  • 33.Morris DW, Trivedi MH. Measurement-based care for unipolar depression. Curr Psychiatry Rep. 2011;13(6):446–458. doi: 10.1007/s11920-011-0237-8 [DOI] [PubMed] [Google Scholar]
  • 34.Zhou J, Wang X, Yang J, et al. Optimization of measurement-based care (OMBC) for depression based on all-round and continuous assessment: rationale and protocol for a multicenter randomized control clinical trial. Trials. 2022;23(1):367. doi: 10.1186/s13063-022-06295-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Lewis CC, Boyd M, Puspitasari A, et al. Implementing measurement-based care in behavioral health: a review. JAMA Psychiatry. 2019;76(3):324–335. doi: 10.1001/jamapsychiatry.2018.3329 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Kaplan C, Cho E, Russo J, et al. The full measure of child mental health: ten lessons learned in launching a division-wide measurement-based care initiative. J Am Acad Child Adolesc Psych. 2023;62:1301–1304. doi: 10.1016/j.jaac.2023.05.023 [DOI] [PubMed] [Google Scholar]
  • 37.Bailey K, Lo LA, Chauhan B, Formuli F, Peck JR, Burra TA. Using a quality improvement approach to implement measurement-based care (MBC) in outpatient general psychiatry. Jt Comm J Qual Patient Saf. 2023;49(10):563–571. doi: 10.1016/j.jcjq.2023.06.009 [DOI] [PubMed] [Google Scholar]
  • 38.Ko H, Gatto AJ, Jones SB, et al. Improving measurement-based care implementation in adult ambulatory psychiatry: a virtual focus group interview with multidisciplinary healthcare professionals. BMC Health Serv Res. 2023;23(1):408. doi: 10.1186/s12913-023-09202-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Shi J, Tang L, Jing L, et al. Disparities in mental health care utilization among inpatients in various types of health institutions: a cross-sectional study based on EHR data in Shanghai, China. BMC Public Health. 2019;19(1):1023. doi: 10.1186/s12889-019-7343-7 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All data generated or analyzed during this study are included in this published article.


Articles from Neuropsychiatric Disease and Treatment are provided here courtesy of Dove Press

RESOURCES